Formula Growth’s NetEase NTES Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-17,105
Closed -$1.47M 161
2020
Q2
$1.47M Sell
17,105
-1,150
-6% -$86.6K 0.25% 93
2020
Q1
$1.17M Sell
18,255
-7,100
-28% -$467K 0.22% 91
2019
Q4
$1.55M Buy
25,355
+10,000
+65% +$586K 0.2% 96
2019
Q3
$817K Sell
15,355
-7,545
-33% -$384K 0.12% 130
2019
Q2
$1.17M Buy
22,900
+12,750
+126% +$677K 0.17% 115
2019
Q1
$490K Sell
10,150
-29,240
-74% -$1.39M 0.07% 140
2018
Q4
$1.85M Buy
+39,390
New +$1.78M 0.31% 69
2018
Q1
Sell
-6,000
Closed -$414K 155
2017
Q4
$414K Buy
+6,000
New +$375K 0.05% 131
2017
Q3
Sell
-53,275
Closed -$3.2M 140
2017
Q2
$3.2M Buy
53,275
+14,325
+37% +$821K 0.55% 47
2017
Q1
$2.21M Buy
+38,950
New +$2.1M 0.46% 60

Other funds holding NTES

Formula Growth's NTES Position: Q3 2020 in Review

Formula Growth sold out of NetEase (NTES) in Q3 2020, closing a stake of 17,105 shares — an estimated $1.47M sold.

Formula Growth first reported a position in NTES in Q1 2017 and held it in 10 quarters. The position peaked at $3.2M in Q2 2017. 465 funds tracked by Wall St. Rank hold NTES as of Q3 2020.

  • Formula Growth reported no remaining NetEase position as of Q3 2020 after selling out during the quarter.
  • Formula Growth sold 17,105 NetEase shares in Q3 2020, an estimated $1.47M.
  • Formula Growth first reported a position in NetEase in Q1 2017 and held it in 10 quarters.
  • Formula Growth's NetEase position peaked at $3.2M in Q2 2017.
  • 465 funds tracked by Wall St. Rank held NetEase as of Q3 2020.

Based on Formula Growth's 13F filing for Q3 2020, filed 16 Nov 2020.